Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valter Gattei

Showing results (111-120 of 190) with videos related to

Pageof 19
Sort By:
Plos One|June 6, 2014
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptorRossana Maffei, Jenny Bulgarelli, Stefania Fiorcari, et al.
British Journal of Haematology|July 14, 2011
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemiaAndrea Rinaldi, Michael Mian, Ivo Kwee, et al.
British Journal of Haematology|April 3, 2004
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemiasFrancesco Buccisano, Francesca Maria Rossi, Adriano Venditti, et al.
Haematologica|August 5, 2018
Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphomaAfua A Mensah, Luciano Cascione, Eugenio Gaudio, et al.
British Journal of Haematology|February 10, 2011
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usageMichele Dal-Bo, Ilaria Del Giudice, Riccardo Bomben, et al.
Haematologica|August 1, 2020
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemiaGiovanni Del Poeta, Annalisa Biagi, Luca Laurenti, et al.
Haematologica|November 14, 2015
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemiaMaria Ilaria Del Principe, Michele Dal Bo, Tamara Bittolo, et al.
Cancer Research|April 23, 2009
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survivalAntonella Zucchetto, Dania Benedetti, Claudio Tripodo, et al.
Blood|September 27, 2013
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanismAntonella Zucchetto, Chiara Caldana, Dania Benedetti, et al.
Haematologica|October 30, 2020
<i>SF3B1</i>-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulationFederico Pozzo, Tamara Bittolo, Erika Tissino, et al.
Pageof 19

Showing results (111-120 of 190) with videos related to

Sort By:
Pageof 19
Plos One|June 6, 2014
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptorRossana Maffei, Jenny Bulgarelli, Stefania Fiorcari, et al.
British Journal of Haematology|July 14, 2011
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemiaAndrea Rinaldi, Michael Mian, Ivo Kwee, et al.
British Journal of Haematology|April 3, 2004
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemiasFrancesco Buccisano, Francesca Maria Rossi, Adriano Venditti, et al.
Haematologica|August 5, 2018
Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphomaAfua A Mensah, Luciano Cascione, Eugenio Gaudio, et al.
British Journal of Haematology|February 10, 2011
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usageMichele Dal-Bo, Ilaria Del Giudice, Riccardo Bomben, et al.
Haematologica|August 1, 2020
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemiaGiovanni Del Poeta, Annalisa Biagi, Luca Laurenti, et al.
Haematologica|November 14, 2015
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemiaMaria Ilaria Del Principe, Michele Dal Bo, Tamara Bittolo, et al.
Cancer Research|April 23, 2009
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survivalAntonella Zucchetto, Dania Benedetti, Claudio Tripodo, et al.
Blood|September 27, 2013
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanismAntonella Zucchetto, Chiara Caldana, Dania Benedetti, et al.
Haematologica|October 30, 2020
<i>SF3B1</i>-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulationFederico Pozzo, Tamara Bittolo, Erika Tissino, et al.
Pageof 19